Apoptosis in sepsis: mechanisms, clinical impact and potential therapeutic targets
- PMID: 18691096
- DOI: 10.2174/138161208784980617
Apoptosis in sepsis: mechanisms, clinical impact and potential therapeutic targets
Abstract
The inability of present therapies to mitigate the devastating effects of sepsis and multiple organ failure in the critically ill patient indicates that more knowledge of the pathophysiology of sepsis is needed if we are to develop better, more effective interventions. This review will examine the concept that a portion of the immune and organ dysfunctions encountered in the septic rodent/ patient is a reflection of not only the types of cells stimulating/ mediating the apoptotic response, but also the varying capacity of the target cell in a given tissue/ organ to perceive these death receptor stimuli as either an apoptotic, inflammatory and/or necrotic signal. We hope the discussion of such studies provides not only new insight into the pathobiology of sepsis, but also suggests possible therapeutic targets for the management of this devastating condition.
Similar articles
-
[New aspects of sepsis pathophysiology in critically ill].Vojnosanit Pregl. 2012 Jan;69(1):58-68. doi: 10.2298/vsp1201058d. Vojnosanit Pregl. 2012. PMID: 22397298 Review. Serbian. No abstract available.
-
Sepsis: links between pathogen sensing and organ damage.Curr Pharm Des. 2008;14(19):1840-52. doi: 10.2174/138161208784980572. Curr Pharm Des. 2008. PMID: 18691095 Free PMC article. Review.
-
Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: Novel therapeutic implications and challenges.Pharmacol Ther. 2017 Sep;177:56-66. doi: 10.1016/j.pharmthera.2017.02.040. Epub 2017 Feb 21. Pharmacol Ther. 2017. PMID: 28232275 Review.
-
A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome.Free Radic Biol Med. 2009 Dec 1;47(11):1517-25. doi: 10.1016/j.freeradbiomed.2009.08.019. Epub 2009 Aug 26. Free Radic Biol Med. 2009. PMID: 19715753 Review.
-
Multiple organ dysfunction syndrome: past, present and future.Surg Infect (Larchmt). 2000 Fall;1(3):155-61; discussion 161-3. doi: 10.1089/109629600750018088. Surg Infect (Larchmt). 2000. PMID: 12594886 Review.
Cited by
-
The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?Virulence. 2014 Jan 1;5(1):45-56. doi: 10.4161/viru.26516. Epub 2013 Sep 25. Virulence. 2014. PMID: 24067565 Free PMC article. Review.
-
Tumor Cell-Derived Exosomal Hybrid Nanosystems Loaded with Rhubarbic Acid and Tanshinone IIA for Sepsis Treatment.J Inflamm Res. 2024 Jul 29;17:5093-5112. doi: 10.2147/JIR.S457978. eCollection 2024. J Inflamm Res. 2024. PMID: 39099664 Free PMC article.
-
Hydrogen sulfide [corrected] increases survival during sepsis: protective effect of CHOP inhibition.J Immunol. 2014 Feb 15;192(4):1806-14. doi: 10.4049/jimmunol.1300835. Epub 2014 Jan 8. J Immunol. 2014. PMID: 24403532 Free PMC article.
-
Baicalin improves survival in a murine model of polymicrobial sepsis via suppressing inflammatory response and lymphocyte apoptosis.PLoS One. 2012;7(5):e35523. doi: 10.1371/journal.pone.0035523. Epub 2012 May 8. PLoS One. 2012. PMID: 22590504 Free PMC article.
-
Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis.Cell Death Dis. 2019 Oct 14;10(10):782. doi: 10.1038/s41419-019-2015-1. Cell Death Dis. 2019. PMID: 31611560 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
